Merck

8 More Big Pharma Events in 2019 You Don't Want to Miss
Motley Fool
Mon, 07/22/19 - 09:44 am
Novartis
Pfizer
AbbVie
Bristol-Myers Squibb
Merck
GSK
Merck’s Keytruda is First to Add Indications Under TGA’s Provisional Approval Pathway
RAPS.org
Wed, 07/17/19 - 11:03 pm
Merck
TGA
Australia
Merck's combination antibiotic scores FDA approval for urinary tract and abdominal infections
Endpoints
Wed, 07/17/19 - 09:46 am
Merck
FDA
UTIs
intra-abdominal infections
Recarbrio
Why Merck is in infectious disease for the long haul
BioCentury
Mon, 07/15/19 - 10:50 pm
Merck
R&D
infectious diseases
antibiotics
The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings
Yahoo/Benzinga
Sun, 07/14/19 - 04:09 pm
Merck
relebactam
TapImmune
earnings
JNJ
Seattle Genetics
Abbott Labs
Intuitive Surgical
Mirum Pharmaceuticals
Fulcrum Therapeutics
Genmab
Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY
Yahoo/Zacks.com
Sat, 07/13/19 - 11:34 am
GSK
HIV
FDA
Merck
Keytruda
Sanofi
isatuximab
Roche
JNJ
With test, Merck takes temperature-controlled drug delivery by drone from remote idea to remote locations
Fierce Pharma
Fri, 07/12/19 - 12:03 pm
Merck
drones
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs
Xconomy
Thu, 07/11/19 - 11:15 pm
Alzheimer's disease
BACE inhibitors
Merck
Eli Lilly
AstraZeneca
Amgen
Novartis
Biogen Eisai
Roche, Merck, Novartis and others hike prices on 83 meds starting in July: analyst
Fierce Pharma
Tue, 07/9/19 - 11:57 am
Roche
Merck
Novartis
drug pricing
FDA Action Alert: Karyopharm, Merck and Celgene
BioSpace
Mon, 07/1/19 - 10:54 pm
FDA
Karyopharm
Selinexor
Merck
relebactam
Celgene
Otezla
Updated HPV Vaccine Recommendations Follow Big HPV Infection Drops Shown In New Study
Forbes
Sun, 06/30/19 - 11:20 pm
vaccines
HPV
Merck
Gardasil
CDC
U.S. advisory panel stops short of broad recommendations for two common vaccines
Stat
Wed, 06/26/19 - 05:15 pm
FDA
vaccines
HPV
pneumonia
advisory panels
Merck
Gardasil
Pfizer
Prevnar 13
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/23/19 - 02:04 pm
Merck
Keytruda
Melinta Therapeutics
Amag Pharmaceuticals
Palatin
Acer Therapeutics
Sanofi
Regeneron
Alexion
Pfizer
Roche
Navidea Biopharmaceuticals
Ascendis Pharma
Scholar Rock
Adaptive Biotechnologies
BridgeBio
IPOs
G Medical Innovations
Karuna
Morphic Therapeutics
Strength of Oncology Pipeline Touted at Merck’s First Investor Day in Five Years
BioSpace
Thu, 06/20/19 - 08:47 pm
Merck
Keytruda
investors
Merck scouts replacements for CEO Frazier less than a year after scrapping retirement rule: report
Fierce Pharma
Wed, 06/19/19 - 10:58 pm
Merck
Pharma CEOs
Ken Frazier
Investor day prep at Merck includes a new strategy to pick up the pace on M&A
Endpoints
Wed, 06/19/19 - 10:12 am
Merck
investors
Keytruda
cancer
M&A
Schrödinger hires ex-Eisai, Merck staff for push into clinic
Fierce Biotech
Wed, 06/19/19 - 09:51 am
Schrödinger
R&D
Eisai
Merck
biotech
Meet the Top Ten Drugs of 2024 (Maybe)
Drug Channels
Tue, 06/18/19 - 11:46 pm
AbbVie
Humira
Merck
Keytruda
Eliquis
Bristol-Myers Squibb
Imbruvica
Opdivo
Revlimid
Celgene
Stepping on Roche's toes, Merck cuts into SCLC niche with second-line Keytruda OK
Endpoints
Tue, 06/18/19 - 10:15 am
Roche
Merck
SCLC
Keytruda
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/16/19 - 05:41 pm
FDA
Merck
Arqule
Affimed
BeiGene
Epizyme
MorphoSys
Theravance
Allena Pharma
Akero Therapeutics
Atreca
Dermavant Sciences
Personalis
Prevail Therapeutics
Stoke Therapeutics
IPOs

Pages